-The Indian Express Manmohan Singh also suggested that the panel — which is looking into the demonetisation decision — call government officials to depose before it hears RBI Governor Urjit Patel. New Delhi: During a meeting of the Parliamentary Committee on Finance on Thursday, former Prime Minister Manmohan Singh sought to know whether the RBI was given sufficient time to hold deliberations on the government’s demonetisation move. He also suggested that the...

-Business Standard The demonetisation drive has hit job creation, beside adding to the stress on banks New Delhi: Demonetisation is expected to negatively impact the overall economy and job generation, a number of economists told Parliament's standing committee on finance. Reserve Bank governor Urjit Patel was to come but could not; he will do so on January 18.   The panel heard four economists — former chief statistician Pronab Sen; Mahesh Vyas, head of...

-The Hindu On the tenth anniversary of the historic passage of the Forest Rights Act, tribal resistance to defend their rights is growing even as government after government tries to dilute its provisions On this day 10 years ago the historic Scheduled Tribes and Other Traditional Forest Dwellers (Recognition of Forest Rights) Act was passed in the Lok Sabha. Its conception and passage was the result of the decades of struggles and...

-The Hindu Only Chandrababu Naidu and Shivraj Singh Chauhan will remain members Bihar’s Nitish Kumar, Tripura’s Manik Sarkar and Puducherry’s V. Narayanasamy have refused the Narendra Modi government’s invitation to join a sub-committee of Chief Ministers on digitisation and cashless transactions. The panel is tasked with suggesting possible ways to ease problems in the wake of the Centre’s demonetisation decision, sources in the Janata Dal (United), the CPI(M) and the Congress confirmed. The panel...

-The Hindu The proposal to extend the time limit for State-level drug regulatory approvals from four to 10 years could hit the generics market In a scathing letter to the Government of India, the Indian Pharmaceutical Alliance (IPA) took issue with what it considered to be a backdoor extension for data exclusivity norms in the country. It pointed to the recent government proposal to change the four-year time limit for State-level drug...